$PALX

$14.34 +$0.33 (2.36%) Close

$PALX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 27.6M shares outstanding

Who owns PALX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 743.6%

Exor N.V. 672.8% · Orbimed Advisors LLC 20.6%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

+1 vs last qtr

Net shares bought

+4.0M

by institutions in Q2 2026

New / sold out

3 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Exor N.V. +3.4M
Gagnon Securities LLC NEW +765.2K

Biggest sellers in Q2 2026

Orbimed Advisors LLC −530.7K
Strategic Investment Solutions, Inc. /IL SOLD OUT −127

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Palomino Laboratories Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+340.5%

+340.48% a year

Each share's claim on the business

−77.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.44M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years3% 3–5 years96% 1–3 years0% Under 1 year1%

Quarterly turnover

1.3%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting PALX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
EN Exor N.V.	185.9M	672.78%	+3.4M (+1.9%)	2023	92.6%
Shares held by quarter Peak holding185.9M (Q2'26) Change over 8 quarters+21.4M Share of the company672.780% Exor N.V.'s full portfolio →
OA Orbimed Advisors LLC	5.7M	20.55%	−530.7K (−8.5%)	≤2021	0.6%
Shares held by quarter Peak holding12.0M (Q3'24) Change over 8 quarters−6.4M Share of the company20.550% Orbimed Advisors LLC's full portfolio →

Exor N.V.

185.9M

% of company

672.78%

Change vs last qtr

+3.4M (+1.9%)

Held since

2023

Orbimed Advisors LLC

5.7M

% of company

20.55%

Change vs last qtr

−530.7K (−8.5%)

Held since

≤2021

6 more super investors behind a free account

See every manager holding Palomino Laboratories Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting PALX on Form N-PORT; together they hold 0.0% of the company

No fund reports holding PALX yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SJ Shealy Jeffrey B. 5%+ holder 13D · 23.8%	4.7M	16.89%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company16.890% Disclosed stake13D · 23.8% View the 13D/G filing →
LP Lucius Partners LLC 5%+ holder 13D · 23.0%	4.0M	14.47%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.470% Disclosed stake13D · 23.0% View the 13D/G filing →

Shealy Jeffrey B.

5%+ holder13D · 23.8%

4.7M

% of company

16.89%

Change vs last qtr

—

Held since

—

Lucius Partners LLC

5%+ holder13D · 23.0%

4.0M

% of company

14.47%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of Palomino Laboratories Inc.

Comments